All Stories

  1. Development, Validation, and Application of an HPLC Method Combined with an In Vitro Model for the Determination of Antibiotic Binding to the Haemoadsorber CytoSorb®
  2. Antibiotics and Other Drugs Removal by the CytoSorb® Haemoadsorber: A Systematic Review of Available Evidence
  3. Strategies to Overcome Hematocrit and Volume Bias in Dried Blood Spot Analysis
  4. Volumetric absorptive microsampling for lumateperone analysis: method validation and stability evaluation
  5. Oxidative Stress-Related Biomarkers in Inflammatory Bowel Disease: Dual Tools for Remission Assessment and Prediction of Treatment Outcome
  6. Clinical pharmacist interventions in medication review for medication optimization in older hospitalized adults with mental disorders and somatic comorbidities: evidence from retrospective study
  7. Development, Validation and Application of the Dried Blood Spot Analysis Method for the Determination of Ustekinumab in Patients with Inflammatory Bowel Disease
  8. Navigating Vancomycin and Acute Kidney Injury: AUC- vs. Trough-Guided Monitoring in Initial and Steady-State Therapy
  9. Assessment of Extracellular Particles Directly in Diluted Plasma and Blood by Interferometric Light Microscopy. A Study of 613 Human and 163 Canine Samples
  10. Oxidative stress-related biomarkers as promising indicators of inflammatory bowel disease activity: A systematic review and meta-analysis
  11. A Cross-Sectional Study Comparing Oxidative Stress in Patients with Epilepsy Treated with Old and New Generation Antiseizure Medications
  12. Supplementation of vitamin E as an addition to a commercial renal diet does not prolong survival of cats with chronic kidney disease
  13. An LC-MS/MS Method for Quantification of Lamotrigine and Its Main Metabolite in Dried Blood Spots
  14. Volumetric absorptive microsampling for the therapeutic drug monitoring of psychiatric patients treated with cariprazine
  15. Evaluation of antioxidant status and lipid peroxidation in dogs with myxomatous mitral valve degeneration stage B1
  16. THE EFFECT OF A SPECIFIC CHICKEN BASED RENAL DIET AS MONOTHERAPY ON CLINICAL, BIOCHEMICAL, URINARY AND SERUM OXIDATIVE STRESS PARAMETERS IN CATS WITH CKD STAGE 1 AND 2
  17. Potential Drug-Drug Interactions among Patients with Schizophrenia Spectrum Disorders: Prevalence, Association with Risk Factors, and Replicate Analysis in 2021
  18. Population pharmacokinetics of cisplatin in small cell lung cancer patients guided with informative priors
  19. Dried Volumetric Microsampling Approaches for the Therapeutic Drug Monitoring of Psychiatric Patients Undergoing Clozapine Treatment
  20. The Effect of Two Acute Bouts of Exercise on Oxidative Stress, Hematological, and Biochemical Parameters, and Rectal Temperature in Trained Canicross Dogs
  21. Ustekinumab Dosing Individualization in Crohn’s Disease Guided by a Population Pharmacokinetic–Pharmacodynamic Model
  22. Effects of Vitamin E and Coenzyme Q10 Supplementation on Oxidative Stress Parameters in Untrained Leisure Horses Subjected to Acute Moderate Exercise
  23. Evaluation of oxidative stress parameters in dogs with brachycephalic obstructive airway syndrome before and after surgery
  24. The Evolving Role of Microsampling in Therapeutic Drug Monitoring of Monoclonal Antibodies in Inflammatory Diseases
  25. VAMS and StAGE as innovative tools for the enantioselective determination of clenbuterol in urine by LC-MS/MS
  26. Antioxidant capacity of lipid- and water-soluble antioxidants in dogs with subclinical myxomatous mitral valve degeneration anaesthetised with propofol or sevoflurane
  27. Peak Concentrations of Ustekinumab After Intravenous Induction Therapy Identify Patients With Crohn’s Disease Likely to Achieve Endoscopic and Biochemical Remission
  28. Determination of 6-thioguanine and 6-methylmercaptopurine in dried blood spots using liquid chromatography-tandem mass spectrometry: Method development, validation and clinical application
  29. Influence of sevoflurane or propofol anaesthesia on oxidative stress parameters in dogs with early-stage myxomatous mitral valve degeneration. A preliminary study
  30. Curriculum Mapping of the Master’s Program in Pharmacy in Slovenia with the PHAR-QA Competency Framework
  31. Control of chemotherapy-induced nausea and vomiting in patients with gastrointestinal tumours
  32. Pharmacokinetics of lamotrigine and its metabolite N-2-glucuronide: Influence of polymorphism of UDP-glucuronosyltransferases and drug transporters
  33. Bisoprolol pharmacokinetics and body composition in patients with chronic heart failure: a longitudinal study
  34. Vitamin E and essential polyunsaturated fatty acids supplementation in schizophrenia patients treated with haloperidol
  35. A simple dried blood spot method for clinical pharmacological analyses of etoposide in cancer patients using liquid chromatography and fluorescence detection
  36. Dried blood spots for monitoring and individualization of antiepileptic drug treatment
  37. Simple and sensitive high performance liquid chromatography method with fluorescence detection for therapeutic drug monitoring of topiramate
  38. Febrile neutropenia in chemotherapy treated small-cell lung cancer patients
  39. Antioxidants as a Preventive Treatment for Epileptic Process: A Review of the Current Status
  40. Simultaneous determination of gabapentin, pregabalin, vigabatrin, and topiramate in plasma by HPLC with fluorescence detection
  41. Oxidative stress in schizophrenia patients treated with long-acting haloperidol decanoate
  42. Population pharmacokinetics of topiramate in adult patients with epilepsy using nonlinear mixed effects modelling
  43. A Simple High-Throughput Method for Determination of Antiepileptic Analogues of γ-Aminobutyric Acid in Pharmaceutical Dosage Forms Using Microplate Fluorescence Reader
  44. Association of SOD2, GPX1, CAT, and TNF Genetic Polymorphisms with Oxidative Stress, Neurochemistry, Psychopathology, and Extrapyramidal Symptoms in Schizophrenia
  45. The Role of Reactive Species in Epileptogenesis and Influence of Antiepileptic Drug Therapy on Oxidative Stress
  46. Plasma malondialdehyde, biochemical and haematological parameters in standardbred horses during a selected field exercise test
  47. Oxidative Stress in Schizophrenia
  48. A Nonlinear Mixed Effects Modelling Analysis of Topiramate Pharmacokinetics in Patients with Epilepsy
  49. Current clinical evidence on topiramate pharmacokinetics
  50. Antioxidant Levels in the Pig Urinary Bladder: Distribution within the Bladder Wall and in the Urothelium Derived from Different Bladder Regions
  51. Comparative study of robustness between micellar electrokinetic capillary chromatography and high-performance liquid chromatography using one-variable-at-a-time and a new multi-variable-at-a-time approach
  52. Sensitive electrochemical detection method for α-acids, β-acids and xanthohumol in hops (Humulus lupulus L.)
  53. HPLC analysis of raloxifene hydrochloride and its application to drug quality control studies
  54. Determination of main low molecular weight antioxidants in urinary bladder wall using HPLC with electrochemical detector
  55. The Correlation between Zeta Potential and Mucoadhesion Strength on Pig Vesical Mucosa
  56. Antioxidative Properties of Pig Vesical Mucosa: A Comparison with Gastric and Intestinal Mucosa.